In this study, we demonstrated that hesperidin and its aglycone, hesperetin, might provide benefits in fighting COVID-19 via blocking the binding of the S protein of SARS-CoV-2 to the human cellular receptor ACE2 and reducing the protein expression of ACE2 and TMPRSS2. The gene discussed is PROS1; the disease is COVID-19.